全文获取类型
收费全文 | 39409篇 |
免费 | 2390篇 |
国内免费 | 129篇 |
专业分类
耳鼻咽喉 | 496篇 |
儿科学 | 1491篇 |
妇产科学 | 1186篇 |
基础医学 | 6179篇 |
口腔科学 | 829篇 |
临床医学 | 3433篇 |
内科学 | 8235篇 |
皮肤病学 | 814篇 |
神经病学 | 4081篇 |
特种医学 | 1402篇 |
外国民族医学 | 14篇 |
外科学 | 5091篇 |
综合类 | 224篇 |
现状与发展 | 1篇 |
一般理论 | 13篇 |
预防医学 | 2658篇 |
眼科学 | 708篇 |
药学 | 2148篇 |
中国医学 | 58篇 |
肿瘤学 | 2867篇 |
出版年
2023年 | 342篇 |
2022年 | 626篇 |
2021年 | 1113篇 |
2020年 | 665篇 |
2019年 | 936篇 |
2018年 | 1036篇 |
2017年 | 791篇 |
2016年 | 960篇 |
2015年 | 938篇 |
2014年 | 1271篇 |
2013年 | 1559篇 |
2012年 | 2292篇 |
2011年 | 2424篇 |
2010年 | 1237篇 |
2009年 | 1185篇 |
2008年 | 1901篇 |
2007年 | 2053篇 |
2006年 | 1878篇 |
2005年 | 1857篇 |
2004年 | 1593篇 |
2003年 | 1530篇 |
2002年 | 1380篇 |
2001年 | 951篇 |
2000年 | 963篇 |
1999年 | 839篇 |
1998年 | 405篇 |
1997年 | 320篇 |
1996年 | 250篇 |
1995年 | 228篇 |
1994年 | 204篇 |
1993年 | 194篇 |
1992年 | 485篇 |
1991年 | 512篇 |
1990年 | 492篇 |
1989年 | 413篇 |
1988年 | 392篇 |
1987年 | 404篇 |
1986年 | 397篇 |
1985年 | 392篇 |
1984年 | 275篇 |
1983年 | 218篇 |
1981年 | 150篇 |
1979年 | 266篇 |
1978年 | 186篇 |
1977年 | 156篇 |
1976年 | 152篇 |
1975年 | 165篇 |
1974年 | 194篇 |
1973年 | 168篇 |
1972年 | 154篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
1.
Emeline Colomba Patricia Pautier Fanny Pommeret Alexandra Leary 《Expert review of anticancer therapy》2019,19(6):437-446
Introduction: The landscape of poly (ADP-ribose) polymerase (PARP) inhibition in ovarian cancer is rapidly evolving and becoming increasingly complex. Ovarian cancer is leading therapeutic innovation by providing the proof of concept for DNA repair as a target. Three different PARP inhibitors have now received approvals in the US and Europe in different indications. Subtle but crucial differences can be found among the licensed indications for each PARP inhibitor in terms of histology, type of BRCA mutation (germline and/or somatic), number of prior lines of chemotherapy and whether the indication is in the treatment or maintenance settings.
Areas covered: We review the latest clinical data regarding the PARP inhibitor rucaparib in ovarian cancer, provide an update on the evolving landscape of PARP inhibition in ovarian cancer, and summarize avenues of ongoing and future research.
Expert opinion: All eligible patients should be offered a PARP inhibitor. SOLO1 trial results demonstrated an unprecedented benefit maintenance with PARP inhibitors in first line. Results from trials evaluating PARP inhibitors as maintenance in first line regardless of BRCA status and from trials evaluating combinatorial strategies are eagerly awaited. 相似文献
2.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients 下载免费PDF全文
3.
4.
Alexandra Katsimardou Konstantinos Imprialos Konstantinos Stavropoulos Alexandros Sachinidis Michalis Doumas 《Expert opinion on pharmacotherapy》2020,21(10):1241-1252
ABSTRACT
Introduction
Type 1 diabetes mellitus (T1DM) is a chronic, autoimmune disease that is characterized by total absence of insulin production. Hypertension is a common comorbidity in T1DM with complex pathophysiology, while it is also a well-recognized risk factor for the development of cardiovascular disease (CVD), as well as other microvascular diabetic complications. 相似文献5.
6.
M. Alexandra Friedman Charlotte M. Niznik Janelle R. Bolden Lynn M. Yee 《Journal of community health》2016,41(2):354-358
While peer support has been investigated in multiple clinical contexts, its application to the postpartum setting is unknown. The aim was to assess acceptability of a postpartum peer support program for women with diabetes. Observational survey-based needs assessment of forty low-income women with diabetes, receiving care at a major medical institution. Mean age and gravidity were 30.7 years and 3.15 ± 1.67 respectively. 45 % expressed interest in a “buddy.” There was no significant difference between groups desiring and not desiring this program. A majority of respondents desired telephone, text messaging, and in-person contacts (79.2, 72.1, 83.8 %), with 72.5 % of patients desiring diabetes-related activities during clinic waiting time. Many women desire a postpartum diabetes reciprocal peer program for support outside of clinician visits. Patients are receptive to educational services during their wait and outside of clinic time, a potentially valuable opportunity to share important health information. 相似文献
7.
Miguel A. Sanz Pau Montesinos Haesook T. Kim Guillermo J. Ruiz-Argüelles María S. Undurraga María R. Uriarte Lem Martínez Rafael H. Jacomo Homero Gutiérrez-Aguirre Raul A. M. Melo Rosane Bittencourt Ricardo Pasquini Katia Pagnano Evandro M. Fagundes Edo Vellenga Alexandra Holowiecka Ana J. González-Huerta Pascual Fernández Javier De la Serna Salut Brunet Elena De Lisa José González-Campos José M. Ribera Isabel Krsnik Arnold Ganser Nancy Berliner Raul C. Ribeiro Francesco Lo-Coco Bob L?wenberg Eduardo M. Rego 《Annals of hematology》2015,94(8):1347-1356
8.
9.
10.
Setting goals to maintain hope. 总被引:3,自引:0,他引:3